Intel Reportedly Readies Mass Layoff
Dylan McGrath, EETimes
4/15/2016 11:00 AM EDT
SAN FRANCISCO — Intel Corp. is preparing to announce significant layoffs that could impact thousands of jobs, according to a report Friday (April 15) by the Portland Oregonian newspaper.
The report, which cites multiple anonymous sources said to be familiar with Intel’s plans, said the cuts would start this spring and continue throughout the year. The report indicates that the move could be announced following Intel’s first quarter earnings report on Tuesday.
Intel, the world’s biggest semiconductor maker, has about 107,000 employees at locations throughout the world. The Oregonian reported that Intel eliminated about 1,100 jobs last year.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- Delay in Mass Production of New Intel Products a Boon for AMD, Proportion of AMD x86 Server CPUs Forecast to Exceed 22% in 2023, Says TrendForce
- TSMC to Kick off Mass Production of Intel CPUs in 2H21 as Intel Shifts its CPU Manufacturing Strategies, Says TrendForce
- Foxconn Reportedly Readies Chip Fab in China
- Intel, Micron Extend NAND Flash Technology Leadership With Introduction of World's First 128Gb NAND Device and Mass Production of 64Gb 20nm NAND
- Intel readies scaleable StrongArm processors for handheld systems
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






